(Total Views: 623)
Posted On: 09/01/2020 5:38:47 PM
Post# of 153917
Teachvike,
The only thing I would l add is that Cytodyn has had success with its 19 employees that few of us could match.
The company pivoted hard into Covid, despite concerns among many that it needed to remain focused on HIV.
It has, in large part, succeeded in navigating regulatory and political hurdles.
Tripping over BLA is frustrating, but the FDA certainly seems to change the rules along the way.
As many have said well, Dr. Pourhassan and his group as scrappy.
Time for us all to buy our Leronlimab Underdog apparel.
The only thing I would l add is that Cytodyn has had success with its 19 employees that few of us could match.
The company pivoted hard into Covid, despite concerns among many that it needed to remain focused on HIV.
It has, in large part, succeeded in navigating regulatory and political hurdles.
Tripping over BLA is frustrating, but the FDA certainly seems to change the rules along the way.
As many have said well, Dr. Pourhassan and his group as scrappy.
Time for us all to buy our Leronlimab Underdog apparel.
(1)
(0)
